Lymphocyte-macrophage colonization in various molecular biological types of endometrial cancer: comparison with the receptor status and proliferative activity of tumor tissue

ORIGINAL ARTICLES. C. CLINICAL RESEARCH

https://doi.org/10.37469/0507-3758-2021-67-3-405-410

Published 06.07.2021

Lev Bershtein
Aleksandr Ivantsov
Aglaia Ievleva
Dmitrii Vasilev
Igor` Berlev

Lev Bershtein

Aleksandr Ivantsov

Aglaia Ievleva

Dmitrii Vasilev

Igor` Berlev

##article.numberofdownloads## 6

##article.numberofviews## 258

pdf (Русский)

Keywords

endometrial cancer
molecular-biological types
features

How to Cite

Bershtein, L., Ivantsov , A., Ievleva , A., Vasilev , D., & Berlev, I. (2021). Lymphocyte-macrophage colonization in various molecular biological types of endometrial cancer: comparison with the receptor status and proliferative activity of tumor tissue. Voprosy Onkologii, 67(3), 405–410. https://doi.org/10.37469/0507-3758-2021-67-3-405-410

Abstract

Recent years have been marked by a gradual shift from the previous division of endometrial cancer (EC) into two main types to modern molecular biological classifications of this disease, one of which (at present, most likely, the most popular: Talhouk et al., 2017, 2019) is based on the use of a combination of genetic and immunohistochemical analysis.

The study involved material from untreated EC patients, the number of which varied depending on the method used. The average age of patients was close to 55-60 years, and over 80% of patients were postmenopausal.

Deparaffinized blocks of EC tissue were analyzed for POLE (DNA polymerase epsilon) mutations, evaluated by immunohistochemistry (IHC) the expression of the oncoprotein p53 and MMR (mismatch-repair) proteins / MLH1, MSH2, MSH6 and PMS2 /, and also helped to identify the type of disease without a characteristic molecular profile (WCMP).

In addition to studying the expression of p53 and MMR proteins, the IHC method was also used to study the expression of estrogen (ER) and progesterone (PR) receptors, the Ki-67 proliferative activity index, and the severity of macrophage-lymphocytic infiltration of the EC tissue based on the analysis of the macrophage marker (CD68) and markers of lymphocytic cells (cytotoxic CD8 and regulatory FoxP3) using reagents from Ventana and Dako.

https://doi.org/10.37469/0507-3758-2021-67-3-405-410

##article.numberofdownloads## 6

##article.numberofviews## 258

pdf (Русский)

References

Talhouk A, McConechy MK, Leung S et al. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer. Cancer. 2017;123(5):802-813. https://doi: 10.1002/cncr.30496.

Берштейн Л.М., Порошина Т.Е., Васильев Д.А., Коваленко И.М. Иванцов А.О., Иевлева А.Г., Берлев И.В. Сравнительные особенности состояния углеводного обмена и массы тела при различных молекулярно-биологических типах рака эндометрия. Вопр. онкол, 2018;64(3):394-398.

Берштейн Л.М., Иевлева А.Г., Иванцов А.О., Васильев Д.А., Клещев М.А., Порошина Т.Е., Коваленко И.М., Венина А.Р., Берлев И.В. Современные молекулярно-биологические типы рака эндометрия: сравнительная эндокринная и провоспалительно-прогенотоксическая характеристика. Вопр. онкол. 2019;65(2):272-278.

Berstein LM, Iyevleva AG, Ivantsov AO, Vasilyev DA, Poroshina TE, Berlev IV. Endocrinology of obese and nonobese endometrial cancer patients: is there role of tumor molecular-biological type? Future Oncol. 2019;15(12):1335-1346. https://doi: 10.2217/fon-2018-0687.

Берштейн Л.М., Иванцов А.О., Иевлева А.Г., Венина А.Р., Берлев И.В. Рецепторный фенотип, экспрессия HER-2/neu, PD1, PDL-1 и лимфоцитарно-макрофагальная инфильтрация карцином эндометрия: сравнение современных молекулярно-биологических типов заболевания (Роль индекса массы тела). Вопр. онкол. 2020;66(1):71-78.

Dun EC, Hanley K, Wieser F, Bohman S, Yu J, Taylor RN. Infiltration of tumor-associated macrophages is increased in the epithelial and stromal compartments of endometrial carcinomas. Int J Gynecol Pathol. 2013;32(6):576-584. https://doi: 10.1097/PGP.0b013e318284e198.

Talhouk A, Derocher H, Schmidt P, Leung S, Milne K, Gilks CB et al. Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma. Clin Cancer Res. 2019;25(8):2537-2548. https://doi: 10.1158/1078-0432.CCR-18-3241.

de Jong RA, Leffers N, Boezen HM, ten Hoor KA, van der Zee AG, Hollema H, Nijman HW. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. Gynecol Oncol. 2009;114(1):105-110.

Eggink FA, Van Gool IC, Leary A, Pollock PM, Crosbie EJ, Mileshkin L, Bosse T. et al. Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition. Oncoimmunology. 2016;6(2):e1264565.

Gadducci A, Guerrieri ME. Immune Checkpoint Inhibitors in Gynecological Cancers: Update of Literature and Perspectives of Clinical Research. Anticancer Res. 2017;37(11):5955-5965.

Szylberg Ł, Karbownik D, Marszałek A. The Role of FOXP3 in Human Cancers. Anticancer Res. 2016;36(8):3789-3794.

Kitson S, Sivalingam VN, Bolton J, Crosbi E J. Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies. Mod.Pathol. 2017;30(3),459-468.

Stelloo E, Jansen AML, Osse EM et al. Practical guidance for mismatch repair-deficiency testing in endometrial cancer. Ann Oncol. 2017;28(1):96-102.

Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999;17(5):1474-1481.

Łapińska-Szumczyk SM, Supernat AM, Majewska HI, Gulczyński J, Biernat W, Wydra D, Żaczek AJ. Immunohistochemical characterisation of molecular subtypes in endometrial cancer. Int J Clin Exp Med. 2015;8(11):21981-21990.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Yekaterina Kuligina, Anna Sokolenko, Ilya Bizin, Aleksandr Ivantsov, Yevgeniy Imyanitov, A. Romanko, M. Anisimova, SEARCHING FOR MISSING HERITABILITY FOR BREAST CANCER BY WHOLE EXOME SEQUENCING: EVALUATION OF VARIANT PATHOGENICITY AND SELECTION OF CANDIDATE MUTATIONS , Voprosy onkologii: Vol. 64 No. 3 (2018)
Tatyana Gorodnova, Nikolay Bondarev, Olga Lavrinovich, Nikolay Mikaya, Yelena Ulrikh, Adiliya Urmancheeva, Yevgeniy Imyanitov, Aleksey Karachun, Aleksey Belyaev, Olga Smirnova, Anna Sidoruk, Khristina Kotiv, Sergey Petrik, Anna Sokolenko, Aleksandr Ivantsov, Katran Guseynov, Zaur Ibragimov, Irina Meshkova, Yekaterina Nekrasova, Igor Berlev, CYTOREDUCTIVE SURGERY FOR OVARIAN CANCER: A REVIEW OF LITERATURE AND ANALYSIS OF THE EXPERIENCE OF THE CLINIC FOR THIRTEEN YEARS , Voprosy onkologii: Vol. 64 No. 3 (2018)
Igor Berlev, Anna Sidoruk, Olga Smirnova, Nikolay Bondarev, Olga Lavrinovich, Nikolay Mikaya, Yelena Ulrikh, Adiliya Urmancheeva, M. Yakoveva, Yekaterina Nekrasova, Irina Meshkova, Aleksandr Ivantsov, Aleksey Belyaev, Aleksey Karachun, Tatyana Gorodnova, Andrey Domanskiy, Yuriy Pelipas, Katran Guseynov, Zaur Ibragimov, Anna Sokolenko, N. Matveeva, CYTOREDUCTIVE SURGERY WITH PERITONECTOMY IN PATIENTS WITH OVARIAN CANCER: TECHNICAL ASPECTS AND IMMEDIATE RESULTS , Voprosy onkologii: Vol. 64 No. 3 (2018)
Lev Bershteyn, Tatyana Poroshina, Zamira Radzhabova, Irina Kovalenko, Aleksandr Ivantsov, Aglaya Ievleva, Igor Berlev, COMPARATIVE FEATURES OF CARBOHYDRATE METABOLISM STATE, BODY WEIGHT AND ASSOCIATED HORMONAL FACTORS IN VARIOUS MOLECULAR-BIOLOGICAL TYPES OF ENDOMETRIAL CANCER , Voprosy onkologii: Vol. 64 No. 3 (2018)
Lev Bershteyn, Aglaya Ievleva, Aleksandr Ivantsov, D. Vasiliev, Maksim Kleshchev, Tatyana Poroshina, Irina Kovalenko, A. Venina, I. Berlev, MODERN MOLECULAR BIOLOGICAL TYPES OF ENDOMETRIAL CANCER: COMPARATIVE ENDOCRINE AND PROINFLAMMATORY-PROGENOTOXIC CHARACTERISTICS , Voprosy onkologii: Vol. 65 No. 2 (2019)
Lev Bershteyn, Aleksandr Ivantsov, Aglaya Ievleva, A. Venina, I. Berlev, STEROID RECEPTOR PHENOTYPE, EXPRESSION OF HER-2/NEU, PD-1, PD-L1 AND LYMPHOCYTIC-MACROPHAGAL INFILTRATION OF ENDOMETRIAL CARCINOMAS: COMPARISON OF MODERN MOLECULAR BIOLOGICAL TYPES OF THE DISEASE (THE ROLE OF BODY MASS INDEX) , Voprosy onkologii: Vol. 66 No. 1 (2020)
Evgenia Vladimirovna, Tatyana Poroshina, Dmitry Vasilev , Diana Enalgieva, Piotr Krivorotko, Lev Bershtein, DNA Damage in Peripheral Blood Mononuclear Cells in Patients with Breast Cancer , Voprosy onkologii: Vol. 69 No. 4 (2023)
Georgiy Gafton, Valentin Anisimov, Dmitriy Matsko, Aleksandr Ivantsov, Ivan Gafton, M. Myasnyankin, LONG-TERM RESULTS OF TREATMENT OF PATIENTS WITH SUBUNGUAL MELANOMA , Voprosy onkologii: Vol. 63 No. 3 (2017)
Lev Bershteyn, Igor Berlev, Aglaya Ievleva, Aleksandr Ivantsov, A. Baltrukova, REMODELING OF THE VIEWS ON ENDOMENTRIAL CANCER: SIGNS AND REALITY , Voprosy onkologii: Vol. 64 No. 1 (2018)
Kirill Zagorodnev, Aleksandr Romanko, Uliy Gorgul, Aleksandr Ivantsov, Anna Sokolenko, Ilya Bizin, Ekaterina Kuligina, Searching for the missing genetic determinants of hereditary breast cancer risk by whole-exome sequencing of BRCA-negative patients: new candidate genes USP39, SLIT3, CREB3 , Voprosy onkologii: Vol. 67 No. 1 (2021)